TheJobsMapGlen Clova Scientific jobs and careers
United Kingdom
About Glen Clova Scientific
Glen Clova Scientific (GCS) is disrupting biologic therapeutic treatment pathways with its unique VLP platform that delivers powerful and accessible therapeutics. With its proprietary virus-like particle (VLP) platform delivering targeted immune modulation, the company is delivering a disruptive alternative to monoclonal antibodies – with lower and faster development cost. The GCS platform is widely applicable for development of vaccines, oncology therapeutics, infectious disease therapeutics and in immune-inflammatory disease.
Founded in 2022 by John Foerster.
- Founded
- 2022
- Employees
- 11 to 50
- Total funding
- $4M
- Headquarters
- United Kingdom
Leadership
The top of Glen Clova Scientific's org chart, with how many people report into each leader.
Jamie C. Hodgson
Chief Executive Officer
Jobs at Glen Clova Scientific
No open positions right now. Explore more companies on TheJobsMap.